Pilar Segovia Calero, Maria Antonia Ramón Belmonte, Mario Culebras Amigo, Iñigo Ojanguren Arranz, A. Gómez
{"title":"Characterization of the lymphocyte phenotype in bronchoalveolar lavage as a prognostic marker in pulmonary sarcoidosis","authors":"Pilar Segovia Calero, Maria Antonia Ramón Belmonte, Mario Culebras Amigo, Iñigo Ojanguren Arranz, A. Gómez","doi":"10.1183/13993003.congress-2019.pa1384","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa1384","url":null,"abstract":"","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132347219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nicol Bernardinello, V. Alfieri, Carlo Turatto, P. Ossola, Elisa Illica Magrini, M. Aiello, E. Crisafulli, A. Chetta, G. Bertorelli
{"title":"Prevalence of Depression in Sarcoidosis: a comparison with asthmatic and healthy controls","authors":"Nicol Bernardinello, V. Alfieri, Carlo Turatto, P. Ossola, Elisa Illica Magrini, M. Aiello, E. Crisafulli, A. Chetta, G. Bertorelli","doi":"10.1183/13993003.congress-2019.pa1952","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa1952","url":null,"abstract":"Introduction: The evaluation and management of psychological well-being has become an increasingly aspect of the approach to chronic respiratory diseases. Aims: Primary aim was to evaluate prevalence and risk of depression in sarcoidosis in comparison with asthmatic patients and healthy controls. Methods: Patients and healthy subjects were examined using the Prime Care Evaluation of Mental Health Disorders (PRIME-MD) questionnaire for the diagnosis of depression, the Hospital Anxiety and Depression Scale (HADS), the Short Form of Health Survey 36 (SF-36) and the Adult Temperament Questionnaire (ATQ). Results: 51 sarcoidosis patients, 48 asthmatic patients and 45 healthy subjects completed all questionnaires. Sociodemographic, clinical characteristics and differences between the three cohorts are shown in Table 1. Sarcoidosis patients were significantly more depressed (p=0.047). In a logistic regression model, even controlling for confounding variables (sex, age, temperament), the presence of a chronic respiratory disease was associated with a three-fold increased risk of developing depression (OR=3.494; 95% CI=1.282-9.518; p=0.014). This risk was almost twice higher (OR=1.85) for those with sarcoidosis compared with those with asthma (Table 2). Conclusion: Sarcoidosis is associated with a greater risk of depression compared to asthma, even when controlling for confounding variables. Multidisciplinary approch might be suggested.","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"57 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127527609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kaat Dekoster, T. Decaesteker, N. Berghen, Anne-Charlotte Jonckheere, Jens Wouters, R. Lories, P. Hoet, J. Vanoirbeek, G. Velde
{"title":"Longitudinal micro-CT-derived biomarkers: the new standard readouts for preclinical evaluation of pulmonary fibrosis and therapy","authors":"Kaat Dekoster, T. Decaesteker, N. Berghen, Anne-Charlotte Jonckheere, Jens Wouters, R. Lories, P. Hoet, J. Vanoirbeek, G. Velde","doi":"10.1183/13993003.congress-2019.pa1960","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa1960","url":null,"abstract":"Pulmonary fibrosis is life-threatening and effective treatment is still lacking. To improve translation of mouse models to man, we introduced an in vivo µCT protocol to repeatedly assess lung fibrosis progression in a silica-induced mouse model. Mice were endotracheally instilled with crystalline silica or saline and scanned weekly for 15 weeks with respiratory gated high-resolution low radiation-dose µCT. We evaluated the disease onset and progress, using biomarkers derived from the scans. At day 7, 35, 63 and 105 after instillation, imaging data were cross-validated with lung function, cellular, histochemical, molecular and histological readouts. Silica instillation resulted in a significant and progressive increase of non-aerated lung volume (corresponding with inflammatory and fibrotic processes) and total lung volume (corresponding to compensatory host response). The aerated lung volume transiently decreased to increase again, indicating an acute inflammatory response. Imaging results were confirmed by a significantly decreased Tiffeneau index (d35 and d63), increased neutrophilic inflammation (d7 - d105), increased IL-13, MCP-1, MIP-2 and TNF-α concentration in BAL fluid (d7 - d105), increased collagen content (d35 - d105) and granuloma formation (d35 - 105). Our findings indicate that µCT is an excellent technique to longitudinally evaluate pulmonary fibrosis, a novel approach that allows assessment of disease progression and stabilization over several weeks. This will facilitate the evaluation of therapeutic interventions at the level of the individual animal.","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"120 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129732370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
V. Sholomova, M. Brovko, L. Akulkina, Laine Francusevica, Lebedeva Mv, L. Samokhodskaya, Krasnova Tn
{"title":"Genetic polymorphisms of the renin-angiotensin system: role in patients with sarcoidosis","authors":"V. Sholomova, M. Brovko, L. Akulkina, Laine Francusevica, Lebedeva Mv, L. Samokhodskaya, Krasnova Tn","doi":"10.1183/13993003.congress-2019.pa1961","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa1961","url":null,"abstract":"Introduction: An important component of renin-angiotensin system (RAS) angiotensin-converting enzyme (ACE) is produced by macrophages in sarcoid granulomas. The role of RAS in sarcoidosis pathogenesis is still unclear. Aim: to assess the role of RAS genes polymorphism in patients with chronic sarcoidosis. Methods: Gene polymorphisms ACE I/D, angiotensinogen (AGT) T704C, angiotensin II receptor type 1 (AGTR1) A1166C and type 2 (AGTR2) G1675A were investigated by polymerase chain reaction (PCR) in 142 Caucasian patients with chronic sarcoidosis (CS) and in 35 healthy volunteers (HV). Results:AC genotype AGTR1 is significantly more frequent in patients with CS than in HV: 29% vs 5% p=0,026,OR=7,364,90%CI 1,3-41,7). The difference between frequency of other genotypes was not significant. In patients with CS there are significant (p<0,05) associations between:\u0000 –CC genotype AGT 704 and the onset age, higher occurrence of coughing, Lofgren syndrome, bone lesions, –AA genotype AGTR1 1166 and higher rate of dyspnea, chest pain, serological inflammatory changes at onset, liver involvement, –AC genotype AGTR1 1166 and higher forced vital capacity (FVC), skin involvement, –GA genotype AGTR21675 and female gender, onset age, higher occurrence of cough, higher FVC, erythrocyte sedimentation rate (ESR), –AA genotype AGTR21675 and liver involvement, –DD genotype ACE and higher frequency of asymptomatic disease course, cough, lower kidney function, –II genotype ACE and higher rate of eye involvement, lower FVC. Conclusion: The heterozygous ATR1 A1166C genotype AC is associated with higher sarcoidosis risk. There are significant associations between the RAS genes polymorphism and the clinical features of sarcoidosis.","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"69 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126442277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
L. Savale, M. Humbert, A. Wells, S. Nathan, R. Gupta, M. Huitema, X. Jaïs, J. Grutters, V. Kouranos, D. Montani, O. Shlobin, O. Sitbon, R. Baughman
{"title":"Algorithm for pulmonary hypertension screening in sarcoidosis: A Delphi Consensus","authors":"L. Savale, M. Humbert, A. Wells, S. Nathan, R. Gupta, M. Huitema, X. Jaïs, J. Grutters, V. Kouranos, D. Montani, O. Shlobin, O. Sitbon, R. Baughman","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4311","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4311","url":null,"abstract":"Since no consensus has been reached on the method for optimal Sarcoidosis associated pulmonary hypertension (SAPH) screening, an international panel of specialists used the Delphi methodology to develop consensus recommendations on SAPH screening in this population. A first panel of 13 members voted on each potential questionnaire tool using a five point Likert scale (Strongly agree to Strongly disagree). The final questionnaire was submitted to 21 specialists. Two successive steps were incorporated: step one examined select features that would lead to echocardiography to screen for SAPH probability according to ERS/ESC guidelines; step two examined echocardiographic parameters that would lead to right heart catheterization (RHC). Consensus was defined when >70% of participants responded to a particular statement with either agree/strongly agreed. The parameters selected by Delphi method to recommend performing echocardiography were persistent dyspnea despite aggressive anti-inflammatory therapy, elevated BNP, main pulmonary artery to aorta ratio> 1, evidence of PH or right ventricular dysfunction on cardiac MRI, a 6-min walk distance 20% of 6-min walk distance or decrease>15% of the DLCO without modification of FVC. Intermediate or high probability of PH on echocardiography should lead to RHC in patients with mild lung disease (FVC≥70%), while only high probability should trigger RHC in patients with moderate to severe lung disease. The Delphi methodology identified specific screening tools that should trigger an echocardiogram. The panel felt the ERS/ESC guidelines for estimating risk for PH in sarcoidosis patients were generally useful.","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"67 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132015720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
E. Yalnız, F. Ucsular, G. Karadeniz, G. Polat, Gorkem Vayisoglu
{"title":"Predictive value of Neutrophil-to-lymphocyte ratio(NLR) and Platelet-to-lymphocyte ratio(PLR) in patients with Sarcoidosis","authors":"E. Yalnız, F. Ucsular, G. Karadeniz, G. Polat, Gorkem Vayisoglu","doi":"10.1183/13993003.CONGRESS-2018.PA3007","DOIUrl":"https://doi.org/10.1183/13993003.CONGRESS-2018.PA3007","url":null,"abstract":"","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"72 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115272433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Long-term outcomes of rituximab (RTX) therapy in recurrent Granulomatosis with Polyangiitis (GPA)","authors":"D. Gawryluk, J. Fijołek, E. Wiatr","doi":"10.1183/13993003.CONGRESS-2018.PA3009","DOIUrl":"https://doi.org/10.1183/13993003.CONGRESS-2018.PA3009","url":null,"abstract":"Between 2012-2018 24 pts (11M,13F) in age 19-78 with refractory or recurrent GPA were treated with RTX (first treatment with 4 weekly infusions 375mg/m2):16 without and 8 with maintenance immunosuppressive treatment (IS). Median follow-up duration was 48 months (34-69). Baseline characteristics and effect of treatment are showed in the table. All but 1 patients achieved remission, all had CD19 depletion and 68% ANCA negativity. Relapse-free survival at 24 months was significantly shorter in pts without IS(20 vs 100%). Median time to ANCA reappearance and Bcell reconstitution were longer in maintenance group. Relapses were treated according to disease severity. Pts with BVAS/GPA 1-5 (7pts) received 1 or 2g RTX without IS, with BVAS 5-18 (6pts) 4 infusions RTX 375 mg/m2 with IS. After RTX retreatment all pts achieved remission, but outcomes in groups with and without maintenance therapy were similar to first RTX: 57%(4/7) without IS recurred after mean time of 24,5 mo (10-37), and all pts on IS sustain remission after mean time of 35 mo (29-44). After RTX retreatment Bcell reconstitution time was similar in both groups (15 mo), but ANCA negativity were more frequent in IS group (80vs16%). 3 pts died at follow-up: 5 mo after 1st, 3 after 2nd and 21mo after 3rd RTX treatment","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"2009 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127334258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
L. Loued, S. Toujani, A. Hedhli, S. Cheikhrouhou, Y. Ouahchi, M. Mjid, Samira Meraii
{"title":"Psychological impact of diffuse infiltrative lung disease","authors":"L. Loued, S. Toujani, A. Hedhli, S. Cheikhrouhou, Y. Ouahchi, M. Mjid, Samira Meraii","doi":"10.1183/13993003.CONGRESS-2018.PA3015","DOIUrl":"https://doi.org/10.1183/13993003.CONGRESS-2018.PA3015","url":null,"abstract":"","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"19 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123545234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
N. Makaryants, A. Ergeshov, N. Demyanenko, L. Lepekha, E. Shmelev
{"title":"Late Breaking Abstract - Characteristics of macrophagal formula and cytokine spectrum of the bronchoalveolar lavage fluid in patients with newly diagnosed and those with recurring sarcoidosis of respiratory apparatus.","authors":"N. Makaryants, A. Ergeshov, N. Demyanenko, L. Lepekha, E. Shmelev","doi":"10.1183/13993003.congress-2018.pa2996","DOIUrl":"https://doi.org/10.1183/13993003.congress-2018.pa2996","url":null,"abstract":"","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"132 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115581690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Martusewicz-Boros, P. Boros, E. Wiatr, J. Zych, A. Kempisty, Marek Kram, D. Piotrowska-Kownacka, S. Wesołowski, R. Baughman, K. Roszkowski-Śliż
{"title":"Cardiac sarcoidosis: worse pulmonary function due to left ventricular ejection fraction ? A case-control study","authors":"M. Martusewicz-Boros, P. Boros, E. Wiatr, J. Zych, A. Kempisty, Marek Kram, D. Piotrowska-Kownacka, S. Wesołowski, R. Baughman, K. Roszkowski-Śliż","doi":"10.1183/13993003.CONGRESS-2018.PA5216","DOIUrl":"https://doi.org/10.1183/13993003.CONGRESS-2018.PA5216","url":null,"abstract":"","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122431312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}